In the wake of failed Alzheimer’s drug trials, scientists are cautiously finding hope with a new strategy

Ken BellLTC News

Gizmodo (03/27/2019) – The field of Alzheimer’s research is one filled with disappointment. Just last week, yet another drug failed its Phase 3 clinical trial, continuing the 15-year-long losing streak since a truly new Alzheimer’s treatment was approved by the Food and Drug Administration. Full story »